Parag Saxena

Insider Reports History

Reporting-owner location: New York, NY
Latest reporting-owner signature: /s/ Parag Saxena
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Parag Saxena

Form 4 holding Director

REVIVA PHARMACEUTICALS HOLDINGS, INC.

Security class: Stock Option (right to buy)
Shares / value: 8,200
Estimated value
Report date: 18 Dec 2025
Price
Ownership: Direct
Underlying class: Common Stock, par value $0.0001 per share
Underlying amount

Insider Reports Filed by Parag Saxena

4 RVPH

REVIVA PHARMACEUTICALS HOLDINGS, INC.

Report period: 18 Dec 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 19 Dec 2025, 16:17
Role: Director
Next action: Open filing details

4 RVPH

REVIVA PHARMACEUTICALS HOLDINGS, INC.

Report period: 10 Dec 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 12 Dec 2024, 16:35
Role: Director, 10%+ Owner
Next action: Open filing details

4 RVPH

REVIVA PHARMACEUTICALS HOLDINGS, INC.

Report period: 20 Nov 2023
Transactions: 2
Transaction value: $0
Accepted by SEC: 22 Nov 2023, 18:28
Role: Director, 10%+ Owner
Next action: Open filing details

4 RVPH

REVIVA PHARMACEUTICALS HOLDINGS, INC.

Report period: 13 Nov 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 14 Nov 2023, 16:18
Role: Director, 10%+ Owner
Next action: Open filing details

4 RVPH

REVIVA PHARMACEUTICALS HOLDINGS, INC.

Report period: 10 Nov 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 14 Nov 2022, 09:34
Role: Director, 10%+ Owner
Next action: Open filing details

4 RVPH

REVIVA PHARMACEUTICALS HOLDINGS, INC.

Report period: 08 Dec 2021
Transactions: 1
Transaction value: $0
Accepted by SEC: 10 Dec 2021, 15:49
Role: Director, 10%+ Owner
Next action: Open filing details

4 RVPH

REVIVA PHARMACEUTICALS HOLDINGS, INC.

Report period: 15 Jun 2021
Transactions: 1
Transaction value: $0
Accepted by SEC: 16 Jun 2021, 18:04
Role: Director, 10%+ Owner
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .